A new Australian company aiming to build further demand for plant-based and alternative proteins has closed a A$16m (US$11.8m) seed capital raise, backed by A$5m (US$3.7m) from the Clean Energy Finance Corporation (CEFC).
Belgian biotech company Inbiose, which develops human milk oligosaccharides (HMOs), has submitted its application for a Generally Recognized as Safe (GRAS) approval by the US Food & Drug Administration (FDA) of four HMOs.
GEA has launched its new nitrogen freezing pilot plant for bacteria, giving dairy processors the opportunity to trial the new technology in their own plants before investing in production-scale equipment.
Chr Hansen has developed cultures for lacto-fermented soy and coconut yoghurts with the taste, texture and healthiness of traditional dairy. ‘It’s still niche but we want to be the first innovators here,” the firm says.
When Julie Smolyansky became president and CEO of kefir market leader Lifeway Foods in 2002 after the sudden death of her father (its founder), the stock went into freefall as investors feared the 27-year old wasn’t ready to run a public company. They...
The global shortage of molasses and competition from biofuels
continue to put upward pressure on prices for yeast, but
opportunities for yeast players lie squarely with the emerging
market for speciality yeast products, and specifically...